The authors have evaluated, via quantitative RT-PCR, its serum exosomal levels in 114 CC patients, as well as in 60 women with CIN and 110 healthy subjects, describing not only significantly higher concentrations of this marker in CC patients versus CIN and controls (p < 0.001 in both instances) but also a positive correlation with lymph node metastasis (p = 0.0071) and FIGO stage (p < 0.0001); in addition, exosomal lncRNA DLX6-AS1 has turned out to be an independent prognostic marker for OS (HR = 3.38, 95% CI = 1.742–6.178, p = 0.009) in multivariate analysis [68]. This evidence concerns the gene DLX6 and cervical squamous intraepithelial neoplasia.